Health ❯ Pharmaceuticals ❯ Drug Regulation

FDA

Compounded Drugs Leadership Changes Compounding Pharmacies Nasal Decongestants Over-the-Counter Medications Oral Decongestants Leadership George Tidmarsh Online Drug Services Carcinogens Enforcement Orders Paracetamol Class II Recall Weight Loss Medications Tirzepatide Oral Phenylephrine

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

The move follows FDA analyses of 91 trials plus a 2.24 million‑patient claims study that found no increased risk.

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Flags Possible License Revocation for Sarepta’s Elevidys

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research